SB 1559

Abstract

Creates the Access to Affordable Insulin Act. Sets forth provisions concerning an insulin urgent-need program. Provides that the Department of Public Health shall establish procedures and applications for the insulin urgent-need program. Sets forth provisions concerning insulin urgent-need program exceptions, eligibility, forms, applications, claims and reimbursement, copayments, information sheets, and navigators. Defines terms. Amends the Illinois Insurance Code. In provisions concerning cost sharing in prescription insulin drugs, provides that an insurer that provides coverage for prescription insulin drugs under the terms of a health coverage plan the insurer offers shall limit the total amount that an insured is required to pay for a 30-day supply of covered prescription insulin drugs at an amount not to exceed $35 (rather than $100). Effective immediately. Senate Committee Amendment No. 1 Provides that the Department of Insurance shall offer a discount program that allows participants to purchase insulin at a discounted, post-rebate price. Sets forth provisions concerning the discount program. Changes the effective date to January 1, 2025 (rather than effective immediately). Removes provisions concerning an insulin urgent-need program. Judicial Note (Admin Office of the Illinois Courts) Based on a review of SB1559 as amended by House Amendment 2, the legislation will not increase or decrease the number of judges needed in the state of Illinois. Balanced Budget Note (Office of Management and Budget) Please be advised that the Balanced Budget Note Act does not apply to Senate Bill 1559, as amended by House Amendment 2, as it is not a supplemental appropriation that increases or decreases appropriations. Under the Act, a balanced budget note must be prepared only for bills that change a general funds appropriation for the fiscal year in which the new bill is enacted. Pension Note (Government Forecasting & Accountability) SB 1559, as amended by HA 2, will have no fiscal impact upon any public pension fund or retirement system in the State of Illinois. Housing Affordability Impact Note (Housing Development Authority) This bill will have no effect on the cost of constructing, purchasing, owning, or selling a single-family residence. State Mandates Fiscal Note, House Floor Amendment No. 1 (Dept. of Commerce & Economic Opportunity) SB 1559 HA #1 and 2 does not create a State Mandate under the State Mandates Act. State Mandates Fiscal Note, House Floor Amendment No. 2 (Dept. of Commerce & Economic Opportunity) SB 1559 HA #1 and 2 does not create a State Mandate under the State Mandates Act. Home Rule Note, House Floor Amendment No. 1 (Dept. of Commerce & Economic Opportunity) SB 1559 HA#1 does not pre-empt home rule authority. Home Rule Note, House Floor Amendment No. 2 (Dept. of Commerce & Economic Opportunity) SB 1559 HA#2 does not pre-empt home rule authority. State Debt Impact Note, House Floor Amendment No. 2 (Government Forecasting & Accountability) SB 1559, as amended by House Amendment 2, would not change the amount of authorization for any type of State-issued bond, and, therefore, would not affect the level of State indebtedness. House Floor Amendment No. 4 Deletes reference to: New Act 215 ILCS 5/356z.41 Adds reference to: 410 ILCS 705/40-5 Replaces everything after the enacting clause. Amends the Cannabis Regulation and Tax Act. Provides that from January 1, 2023 through January 1, 2027, the Department of Agriculture shall not make the application available for transporting organization licenses. Provides that entities awarded a transporting license shall not be required to pay any fee required under the Transporting Organizations Article of the Act, the nonrefundable renewal fee required under that Article, or any other license fee required under that Article or by rule from January 1, 2024 to January 1, 2027. Provides that upon completion of the disparity and availability study published by the Illinois Cannabis Regulation Oversight Officer, the Department may modify or change the licensing application process to reduce or eliminate barriers and remedy discrimination identified in the study. Effective immediately.